No products in the cart.
TSPAN33: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD
It’s the GeneMedi’s summary page for Target/Biomarker Introduction of TSPAN33. The page also collects GeneMedi’s different modalities and formats products for TSPAN33 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the TSPAN33 target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Transmembrane Protein.
Enables enzyme binding activity. Involved in pore complex assembly; protein localization to plasma membrane; and protein maturation. Located in plasma membrane. Part of pore complex. [provided by Alliance of Genome Resources, Apr 2022]
|
Target ID |
GM-MP1884
|
|
Target Name |
TSPAN33
|
|
Gene ID |
340348
|
|
Gene Official Name |
TSPAN33
|
|
Gene Alias |
PEN, PEN., TSPAN-33
|
|
Protein Sub-location |
Transmembrane Protein
|
|
Category |
|
Anti-TSN33/ TSPAN33/ PEN antibody for FACS & in-vivo assay| GMab
Pre-made anti-TSPAN33 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-TSPAN33 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Filters
Sort results
Reset
Apply
Cat No. | Antibody Name | Format | Classified by tag | Order
|
|---|---|---|---|---|
Anti-TSPAN33 monoclonal antibody |
mab |
FACS/Biofunctional Antibody |
